Literature DB >> 3795035

Studies on the mechanism of absorption and distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.

M R Lakshmanan, B S Campbell, S J Chirtel, N Ekarohita, M Ezekiel.   

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), the toxic contaminant of Agent Orange, is absorbed essentially by the lymphatic route and is transported predominantly by chylomicrons after intestinal absorption. Plasma disappearance of [3H]TCDD-labeled chylomicrons followed first-order decay kinetics, with two exponential components having half-lives of 0.8 and 30 min, respectively. Liver and adipose tissues together accounted for 74 to 81% of the total radioactivity distributed among various tissues. The i.p. route of administration was as effective as the oral route for uptake in 24 h by the adipose and liver tissues, whereas the s.c. route was less efficient. Adipose tissue exhibited a progressive accumulation of labeled TCDD during the first 24 h, whereas the liver showed an exponential disappearance of the newly absorbed TCDD with a half-life of 21.3 h. In contrast, long-term pharmacokinetics of TCDD in the adipose and liver tissues revealed exponential decay patterns with half-lives of 7.6 and 5.3 weeks, respectively. These results show that the adipose tissue and the liver are the major sites of TCDD storage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3795035

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

Review 1.  Factors affecting the storage and excretion of toxic lipophilic xenobiotics.

Authors:  R J Jandacek; P Tso
Journal:  Lipids       Date:  2001-12       Impact factor: 1.880

2.  Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.

Authors:  K Abraham; R Krowke; D Neubert
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

3.  Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on de novo fatty acid and cholesterol synthesis in the rat.

Authors:  M R Lakshman; B S Campbell; S J Chirtel; N Ekarohita
Journal:  Lipids       Date:  1988-09       Impact factor: 1.880

4.  Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.

Authors:  Claude Emond; Linda S Birnbaum; Michael J DeVito
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

5.  The Association between Blood Concentrations of PCDD/DFs, DL-PCBs and the Risk of Type 2 Diabetes Mellitus and Thyroid Cancer in South Korea.

Authors:  SuHyun Lee; YoungWook Lim; YounSeok Kang; KeumJi Jung; SunHa Jee
Journal:  Int J Environ Res Public Health       Date:  2022-07-18       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.